ARTICLE | Clinical News
Cotara: Phase I data
June 9, 2008 7:00 AM UTC
Data from 3 evaluable patients in an open-label, U.S. Phase I trial showed that the concentration of Cotara in brain tumors was >100-fold higher than in other organs after interstitial dosing. All pat...